Despite the pandemic, and partially even because of it, life sciences is booming. Paul Hastings, ranked No. 24 on the Am Law 100, continues to strike while the iron is hot, adding former Sidley Austin FDA regulatory and enforcement partners Nathan Sheers and Peter Lindsay to the practice, the firm announced Wednesday. Both will be based out of the firm’s Washington, D.C., office.
The firm announced the formation of its new life sciences consulting group with former Deloitte consultant BJ D’Avella in June, and these latest hires are further evidence that the firm is going big on life sciences.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]